Development and validation of hypermethylated gene markers in cervical cytological samples for detecting endometrial cancer (EndoMethy-I trial) - Quiz - MDSpire

Development and validation of hypermethylated gene markers in cervical cytological samples for detecting endometrial cancer (EndoMethy-I trial)

  • By

  • Xiaojing Chen

  • Lixin Liu

  • Xitong Jin

  • Yanan Cheng

  • Huanwen Wu

  • Yan You

  • Yuligh Liou

  • Pei Liu

  • Jinghe Lang

  • Lei Li

  • June 19, 2026

  • 0 min

Share

Original Source(s)

Development and validation of hypermethylated gene markers in cervical cytological samples for detecting endometrial cancer (EndoMethy-I trial)

  • by Xiaojing Chen, Lixin Liu, Xitong Jin, Yanan Cheng, Huanwen Wu, Yan You, Yuligh Liou, Pei Liu, Jinghe Lang, Lei Li

  • June 19, 2026

Related Content

Hepatic metastasis of mucinous adenocarcinoma with neuroendocrine differentiation harboring a rare HER2 R678Q mutation: a case report and literature review

Past present and future of radiosensitization in cervical cancer

Case Report: Exchange transfusion for hemolytic anemia and acute kidney injury associated with hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin in a patient with hepatocellular carcinoma